Postoperative Ileus
Conditions
Brief summary
The goal of the BEET IT study is to examine if preoperative intake of beetroot juice can ameliorate gastrointestinal (GI) recovery after colorectal surgery and thereby help to reduce the duration of postoperative ileus (POI) and prevent prolonged POI. Adult patients undergoing laparoscopic colorectal surgery are randomized 1:1 to consume either concentrated beetroot juice (active intervention) or nitrate-depleted concentrated beetroot juice (placebo) during the week before their surgery. Blood, tissue and/or fecal samples are collected at specific time points pre- and/or postoperatively to study markers related to inflammation, oxidative stress and GI function. Patients are followed from the week before surgery (start of the intervention) until 3 months post-surgery. The study takes place at 5 hospitals in Flanders, Belgium.
Detailed description
Postoperative ileus (POI), a transient impairment of gastrointestinal (GI) motility, remains one of the most common complications following abdominal surgery. It is characterized by the presence of nausea and vomiting, the inability to tolerate oral diet, abdominal distension and delayed passage of flatus and stool. POI usually resolves within 3 to 5 days, but when prolonged, it can lead to increased morbidity, prolonged hospitalization and increased healthcare costs. In patients undergoing colorectal surgery, the reported incidence of prolonged POI (PPOI) is 10.2%. Prevention and treatment remains mainly supportive and no single effective treatment is currently available. Because of its multifactorial origin and possible exogenous factors, prevention and treatment generally requires a multimodal approach. Many of these strategies are part of the Enhanced Recovery after Surgery (ERAS) program. The pathophysiology of POI is marked by an acute neurogenic phase followed by a prolonged inflammatory phase and alterations in the enteric neurotransmission. The pathogenesis involves inflammation and oxidative stress, similar to ischemia/reperfusion (I/R) injury. Both I/R injury and POI are associated with downregulation of nitric oxide (NO) synthases. In this sense, beetroot juice holds considerable promise. Beetroot is a rich source of inorganic nitrate. Consumption of nitrate-rich foods increases the concentration of NO metabolites in the blood and tissues via the enterosalivary nitrate-nitrite-NO pathway, independently of the traditional pathway via the endogenous NOS enzymes, which tends to become less effective in older age and in environments wherein oxygen availability is limited such as during hypoxia and I/R injury. Interest goes to the effects of preoperative beetroot juice supplementation on postoperative GI recovery and POI duration after laparoscopic colorectal surgery. A proof of concept study with 12 patients at our lab already showed promising results. We now want to validate the results in a bigger group of patients via a multicentric double-blind randomized controlled prospective phase II study.
Interventions
DIETARY_SUPPLEMENTconcentrated beetroot juice
Nitrate supplementation; natural source of dietary nitrate
Sponsors
University Hospital, Ghent
Research Foundation Flanders
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Masking description
Beetroot juice bottles are delivered at the central investigational site in labeled boxes indicating whether they are active or control juice. The bottles themselves are identical in appearance and only distinguishable by the manufacturer through the production code. Blinding of the juices is done by an independent party who is responsible for removing the labels, indicating whether the juices are active or nitrate-depleted juice, from the boxes, and assigning an intervention letter code to active or control beetroot juice as 'A' or 'B', without revealing which is which. Sets of 7 bottles, corresponding with the dosage regimen, from A or B according to the randomization list made by an independent statistician, are then labelled with an unique randomization letter code comprising of 2 randomly generated letters, followed by an underscore and a numerical index from 1 to 7 (e.g. AX\_1,…, AX\_7) to assure allocation concealment.
Intervention model description
Multicentric double-blind randomized controlled prospective phase II study
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult patients undergoing elective colonic and upper rectum laparoscopic surgery requiring an anastomosis, without the need of conversion
Exclusion criteria
General: * \< 18 years of age * Pregnancy or breast feeding Medical: * Psychiatric pathology capable of affecting comprehension and judgment faculty * History of inflammatory bowel disease * Chronic vascular disease affecting the intestines * Chronic constipation (\<= 2 bowel movements/week) * Previous abdominal or pelvic radiation treatment * Recent (\< 3 months before inclusion) or current intra-abdominal infection or inflammation (e.g. diverticulitis, appendicitis, cholecystitis) * Use of gut motility influencing agents (e.g. tricyclic antidepressants, chronic use of laxatives) * Use of nitrates (e.g. isosorbide dinitrate, nitroglycerin), including daily consumption of beetroot juice (unless stopped for a month prior to the intervention period) * Hypotension (\< 100/60 mmHg) * Uncontrolled diabetes mellitus * Renal or hepatic insufficiency * Known allergies or intolerances to beetroot, nitrates/nitrites * Enrollment in other clinical trials/experiments, unless approved by the Ethics Committee(s) Surgical: * History of prior colorectal surgery * Emergency surgery * Open surgery * Colorectal surgery not requiring an anastomosis (e.g. colotomy, wedge resection) * More than 1 bowel anastomosis planned * Concomitant surgical procedures required (e.g. resection of liver or lung metastases) * Protective stoma planned
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative recovery of gastrointestinal (GI) function | hours after the end of surgery (suture) | composite endpoint requiring recovery of both upper GI functions (tolerance of a solid diet) and lower GI functions (passage of flatus and stool) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| First passage of flatus | first occurence after the end of surgery (suture) | recorded in postoperative days (standard of care) and hours (self-reported in the patient diary) |
| First passage of stool | first occurence after the end of surgery (suture) | recorded in postoperative days (standard of care) and hours (self-reported in the patient diary) |
| First tolerance of liquids | first occurence after the end of surgery (suture) | liquids: no chewing required, can be quickly swallowed as such, can be ingested with a straw (e.g. water, coffee, tea, juice, soda), recorded in postoperative days (standard of care) and hours (self-reported in the patient diary) |
| First tolerance of a semi-solid diet | first occurence after the end of surgery (suture) | semi-solid food: no or limited biting and chewing required, can be easily swallowed, usually ingested with a spoon or fork (e.g. yoghurt, eggs, soft cheeses), recorded in postoperative days (standard of care) and hours (self-reported in the patient diary) |
| First tolerance of a solid diet | first occurence after the end of surgery (suture) | solid food: proper and sustained biting and chewing required, cannot be swallowed as such, a knife is usually required to cut the food (e.g. steak, raw vegetables, crisp fruit), recorded in postoperative days (standard of care) and hours (self-reported in the patient diary) |
| Incidence and recovery of PPOI | until hospital discharge after surgery | according to the PPOI definition of Vather et al., 2013 |
| Postoperative length of hospital stay | until hospital discharge after surgery | from the end of surgery (day 0) until discharge (alive) from hospital, recorded in days (standard of care) |
| Number and types of postoperative complications | until 3 months after surgery | according to Clavien-Dindo, CCI |
| Levels of specific biomarkers in blood, tissues and/or feces | 4 time points: (1) inclusion, (2) day of surgery, (3) postoperative day 1, (4) postoperative day 3 | markers for inflammation and oxidative stress, NO bioavailability, intestinal barrier function and permeability |
Countries
Belgium
Contacts
CONTACTWim Ceelen, MD, PhD
CONTACTKaren De Meuleneir, MSc
Outcome results
None listed